Navigation Links
Hundred million dollar gift for malaria institute

An anonymous donor has gifted 100 million dollars to Johns Hopkins University in the United States of America to set up a malaria institute. This would be the world’s foremost center for malaria research in the world.

Public health experts say the Johns Hopkins Malaria Institute will put the university at the forefront of efforts to find an effective vaccine and new treatments for the mosquito-borne disease, one of the leading killers in developing nations. Malaria kills atleast one million people and at least 500 million get infected every year. Apart from AIDS/HIV and Tuberculosis, malaria is the most deadly infectious disease in the world.

Some health facilities use bed nets, treated with insecticide, to curtail the disease but Johns Hopkins is among the few institutions trying to develop a successful vaccine or new drug treatments.

Dr. Diane Griffin, professor and chair of the Department of Molecular Microbiology and Immunology, will oversee the project. University officials ultimately expect the program to have 12 lead scientists and between 120 and 200 researchers and graduate scientists
'"/>




Page: 1

Related medicine news :

1. Man Arrested For Sending Hundreds Of Anthrax Hoax Letters
2. Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK
3. Hundreds of human tissue products been recalled
4. Burning fires in Northern Ontario Cause Hundreds to leave their Homes
5. Does C-Section Stand for ‘Concern’? Study Reveals One in Hundred Babies ‘Hut’
6. Hundreds dying in northeast from AIDS
7. Hundreds of Children Put on a Trial to Trace the Cause of Peanut Allergy
8. Hundreds Literally Sea ‘sick’ on Luxury Linr
9. Hundreds of Turkeys Die Due to Bird Flu
10. Sex – Three Hundred Years Ag
11. George Bush pledges 200 million dollars for AIDS relief
Post Your Comments:
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...nn., May 16 /PRNewswire-USNewswire/ -- This releas...Clinic in conjunction with the,National Cancer Ins...eing presented at the American Society of Clinical... change treatment practice,in about 25 percent of ...oposed changes to the way colorectal cancers will ...
(Date:5/16/2008)...ng presented at the American Society of Clinical O...hange treatment practice in about 25 percent of pa...osed changes to the way colorectal cancers will be...er Institute (NCI) SEER population-based statistic...cal trial data, shows that outcomes of patients wi...
(Date:5/16/2008)...eclaring that Primary care medicine is in a precip...of the American College of Physicians (ACP), today... and consumers to issue a call for comprehensive r...rnists and other primary care physicians. , Dur...e medicine in the U.S., Dr. Dale and other panelis...
Breaking Medicine News(10 mins):Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2
...t women are to be monitored more carefully accord...ine Conference// in San Francisco, as they are at ..., than previously known. Mert Ozan Bahtiyar of ...t forward results made after an extensive study of...
...ation of genes that are responsible for diabetes h...pot potential diabetics//. This study has been rep...Froguel of Imperial College, London who conducted ... hereditary and life style patterns are linked to ...
...gift for those burdened with shyness and impotence...to see// a doctor. Boots Pharmacy, UK has announc... men suffering from erectile dysfunction in UK al...s that can be sold over the counter (OTC). Other...
... Kimmel Cancer Center scientists have found a set ... stem cells in their primitive state//. Unlocking ...o grow new blood cells for transplant into patient...orders. The scientists located the control switch...
Other Medicine News:Health News:Viagra to Be an OTC Drug Soon 2Health News:Master Switches Found for Adult Blood Stem Cells 2
(Date:5/15/2008)...LWORTH, N.J., May 15 /- Sch...n advancing the science and treatment of,chronic h...that data from,several clinical studies with PEGIN...ibavirin, USP) combination therapy, as well as boc...otease inhibitor, will be presented at,the 39th an...
(Date:5/15/2008)...GEWATER, N.J., May 15 /- Sa...ed today that findings from the,landmark ATHENA st...erapy,for the treatment of patients with atrial fi...f cardiovascular hospitalizations or death from an...000002), meeting the study,primary endpoint. The A...
(Date:5/15/2008)...ARBOR, Mich. and TOULOUSE, France, May 15 /PRNewsw...tely held pharmaceutical company,developing HDL-re...r and,metabolic diseases, today announced that it ..., one of the company,s lead product candidates.,CE...tor (PPAR),delta-specific agonist in development f...
(Date:5/15/2008)...ON, May 15 /- CenterWatch, a publishi...ket research about clinical,trials, finds that inv...C,(electronic data capture) systems. More than 75%...icated that they had been trained on three or more...at the effectiveness of,their EDC training had imp...
Breaking Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2MGT Comments on American Cancer Societys Decision to Endorse CT Colonography 13758 1MGT Comments on American Cancer Societys Decision to Endorse CT Colonography 13758 2MGT Comments on American Cancer Societys Decision to Endorse CT Colonography 13758 3MGT Comments on American Cancer Societys Decision to Endorse CT Colonography 13758 4Alexzas Corporate Presentation to be Webcast at the Cowen 26 Company 28th Annual Health Care Conference 13755 1Alexzas Corporate Presentation to be Webcast at the Cowen 26 Company 28th Annual Health Care Conference 13755 2Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call 3790 1Abbott to Present at Lehman Brothers Healthcare Conference 3786 1Abbott to Present at Lehman Brothers Healthcare Conference 3786 2
... CTI OTCBB: CHKT, VANCOUVER, March 12, 2007 /PRNew...Chemokine Therapeutics" or the "Company") , a,biot...pies to treat,cancer, blood disorders, and vascula...a and the successful completion of the,dose-escala...,CTCE-9908, the Company,s anti-cancer drug candida...
...LOUIS--(BUSINESS WIRE)--Mar 12, 2007 - GenoMed (OT...anagement company whose,business is public health(...of a sickle cell patient whose pain has disappeare...The patient is a middle-aged African American woma... day to tolerate the pain,of her sickle cell disea...
Other Medicine Technology:Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5GenoMed Prevents Sickle Cell Pain for Over a Year 2
For regulating sample flow rate when using the QIAvac 24 Plus;
For connecting the QIAvac 24 Plus and Vacuum Pump;
DNA/RNA preparation in 384-well format
...h hydrophobic PTFE membranes,Millex filter units w...the sterilizing filtration of gases, for venting o...fying organic solutions. Ready-to-use sterile 25 m... outlet connections; other filter units can be aut...
Medicine Products: